Resultado da Busca
3 de abr. de 2024 · Explore a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
- Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care ...
Vaccine Effectiveness. For the period of 0 to 9 days after...
- Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care ...
10 de dez. de 2020 · Here, we report safety and efficacy findings from the phase 2/3 part of a global phase 1/2/3 trial evaluating the safety, immunogenicity, and efficacy of 30 μg of BNT162b2 in preventing...
- Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen ...
- 2020
9 de abr. de 2024 · Coverage of latest information on COVID-19 from across the medical literature and put into context for you by NEJM Journal Watch editors. Articles. Filter by Date. Apr 10, 2024. |. Infectious Diseases. Hospital Medicine. Monoclonal Antibody Receives Emergency Use Authorization for Preventing COVID-19 in High-Risk Patients. Daniel Kaul, MD.
28 de set. de 2023 · Persistent coronavirus disease 2019 (covid-19) symptoms are increasingly well-reported in the literature. These persistent symptoms following acute infection, otherwise known as ‘long covid’, have affected people worldwide. Long covid is a heterogeneous disease with multimorbidities affecting several physiological systems.
In the absence of clinical trial results, physicians must use what has been learned about the pathophysiology of SARS-CoV-2 infection in determining early outpatient treatment of the illness with the aim of preventing hospitalization or death.
7 de ago. de 2020 · Abstract. Approximately 9 months of the severe acute respiratory syndrome coronavius-2 (SARS-CoV-2 [COVID-19]) spreading across the globe has led to widespread COVID-19 acute hospitalizations and death.
